-
sodium (4aR,6R,7R,7aS)-6-{2-amino-8-[(4-chlorophenyl)sulfanyl]-6-oxo-6,9-dihydro-1H-purin-9-yl}-7-hydroxy-2-oxo-hexahydro-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-2-olate
-
ChemBase ID:
155352
-
Molecular Formular:
C16H14ClN5NaO7PS
-
Molecular Mass:
509.793191
-
Monoisotopic Mass:
508.9937774
-
SMILES and InChIs
SMILES:
c1cc(ccc1Sc1nc2c(=O)[nH]c(nc2n1[C@H]1[C@@H]([C@H]2[C@H](O1)COP(=O)(O2)[O-])O)N)Cl.[Na+]
Canonical SMILES:
O[C@@H]1[C@@H]2OP(=O)([O-])OC[C@H]2O[C@H]1n1c(Sc2ccc(cc2)Cl)nc2c1nc(N)[nH]c2=O.[Na+]
InChI:
InChI=1S/C16H15ClN5O7PS.Na/c17-6-1-3-7(4-2-6)31-16-19-9-12(20-15(18)21-13(9)24)22(16)14-10(23)11-8(28-14)5-27-30(25,26)29-11;/h1-4,8,10-11,14,23H,5H2,(H,25,26)(H3,18,20,21,24);/q;+1/p-1/t8-,10-,11-,14-;/m1./s1
InChIKey:
REEQGIQRCDWDRA-ZBMQJGODSA-M
-
Cite this record
CBID:155352 http://www.chembase.cn/molecule-155352.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium (4aR,6R,7R,7aS)-6-{2-amino-8-[(4-chlorophenyl)sulfanyl]-6-oxo-6,9-dihydro-1H-purin-9-yl}-7-hydroxy-2-oxo-hexahydro-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-2-olate
|
|
|
IUPAC Traditional name
|
sodium (4aR,6R,7R,7aS)-6-{2-amino-8-[(4-chlorophenyl)sulfanyl]-6-oxo-1H-purin-9-yl}-7-hydroxy-2-oxo-tetrahydro-4H-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-2-olate
|
|
|
Synonyms
|
8-pCPT-cGMP
|
pCPT-cGMP
|
8-(4-Chlorophenylthio)-guanosine 3′,5′-cyclic monophosphate sodium salt
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
1.8410523
|
H Acceptors
|
8
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-0.81009865
|
LogD (pH = 7.4)
|
-0.8330265
|
Log P
|
1.4516176
|
Molar Refractivity
|
107.5555 cm3
|
Polarizability
|
41.982513 Å3
|
Polar Surface Area
|
173.35 Å2
|
Rotatable Bonds
|
3
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
C5438
|
Biochem/physiol Actions Membrane-permeable analog of cGMP that does not affect cGMP-regulated phosphodiesterase. A more potent cGMP analog than 8-Br-cGMP due to greater membrane permeability and a higher resistance to hydrolysis by phosphodiesterase. Used as a selective activator of cGMP dependent protein kinase (PKG). Found to be a very potent cyclic nucleotide-gated channel agonist. |
PATENTS
PATENTS
PubChem Patent
Google Patent